The two-dose vaccine regimen failed to give 2- to 5-year-olds a robust immune response.
Parents hoping that a coronavirus vaccine will soon become available for their babies and young children may be waiting even longer following
Although the vaccine did generate an adequate immune response in children six months to two years old, the companies reported that two doses of the pediatric vaccination – at 3 micrograms each, they are one-tenth of the adult dose – was not as robust in 2-, 3-, and 4-year-olds as compared to people 16 years and older.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Weiterlesen »
Omicron May Require Fourth Vaccine Dose, Pfizer SaysThe new Omicron variant could make it more likely that people will need a fourth coronavirus vaccine earlier than expected, Pfizer officials said on Wednesday.
Weiterlesen »
Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Weiterlesen »
Low-dose Pfizer-BioNTech vaccine fails in trial on 2 to 5 year oldsA low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two through five years of age.
Weiterlesen »
Venus Retrograde Means We’re Getting A Dose Of Tough LoveEven if you know nothing about astrology, you've probably heard of a little something called retrograde. One planet in particular — Venus, the Planet of Love, Money, and Affection — goes retrograde once every year and a half for around 40 days, and it can be intense.
Weiterlesen »
Pfizer's child-sized vaccine fails to produce immunity in younger kids; company adds third dose to trialsVaccine maker Pfizer said Friday that trials of its vaccine in children ages 2 to 5 show it did not provide the expected immunity in kids this age and it is adding a third dose to the regimen.
Weiterlesen »